Top 5 Healthcare Stocks the Experts at Sphera Global Healthcare Fund Are Buying
Below we present the list of the top 5 healthcare stocks the experts at Sphera Global Healthcare Fund are buying.
Syndax Pharmaceuticals Inc (SNDX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Avidity Partners Management David Witzke And Michael Gregory | 4,823,400 | $83,831 | 1.74% | |
| 2. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,692,303 | $46,792 | -6% | 2.07% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,394,714 | $41,620 | +15% | 1.66% |
| 4. | VenBio Select Advisor Kurt Von Emster | 2,220,500 | $38,592 | +3% | 0.7% |
| 5. | OrbiMed Advisors Samuel Isaly | 2,158,300 | $37,511 | +9% | 0.6% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.46 | 500 | 15,666 | 2021-04-26 | Filing | ||
| $14.11 | 13,967 | 43,300 | 2021-04-22 | Filing | ||
| $8.00 | 12,500 | 43,900 | 2020-02-04 | Filing | ||
| $5.40 | 11,000 | 31,400 | 2019-10-10 | Filing | ||
| $7.29 | 7,200 | 20,400 | 2019-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.29 | 3,128 | 17,836 | 2022-04-04 | Filing | ||
| $17.46 | 70,545 | 17,836 | 2022-04-01 | Filing | ||
| $17.44 | 24,500 | 17,836 | 2022-04-01 | Filing | ||
| $17.44 | 6,000 | 42,336 | 2022-04-01 | Filing | ||
| $16.65 | 1,412 | 0 | 2022-02-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 38,872 | $675,595 | 0% | |
| 2. | 37,859 | $657,989 | 0% | |
| 3. | 3,798,150 | $66,011 | 0% | |
| 4. | 3,195,403 | $55,536 | 4.73% | |
| 5. | 2,432,438 | $42,277 | 0% |
News See All
Hedge Funds Are Crazy About Syndax Pharmaceuticals, Inc. (SNDX)
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Should I Avoid Syndax Pharmaceuticals, Inc. (SNDX)?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
10 Best Biotech Stocks to Buy According to Alan Frazier’s Frazier Healthcare Partners
In this article, we discuss the 10 best biotech stocks to buy according to Alan Frazier.
Syndax Pharmaceuticals, Inc. (SNDX) Fell Out Of Favor With Hedge Funds
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
Is SNDX Stock A Buy or Sell?
After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Hedge Funds Are Truly Crazy About Syndax Pharmaceuticals, Inc. (SNDX)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Syndax Pharmaceuticals, Inc. (SNDX) ?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Funds Have Never Been This Bullish On Syndax Pharmaceuticals, Inc. (SNDX)
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March...
Should You Avoid Syndax Pharmaceuticals, Inc. (SNDX)?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Billionaire Hedge Funds
